FDA Issues Nationwide Recall for One Lot of Xanax XR Tablets
One lot of Xanax XR, the extended-release form of the popular anti-anxiety medication, has been recalled nationwide by the FDA after failing key quality standards. It is the latest in a string of recent drug recalls to affect products sold through major U.S. pharmacies.
What Is Being Recalled
The recall affects 3mg Xanax XR tablets sold in 60-tablet bottles, Lot #8177156, with an expiration date of February 28, 2027. The recall was initiated on March 17 by the drug's distributor, Viatris Specialty LLC, and expanded to a nationwide recall on April 16, 2026.
According to the California State Board of Pharmacy, the affected pills were distributed to patients between August 27, 2024, and May 29, 2025.
Why the Drug Was Recalled
The FDA cited "failed dissolution specifications" as the reason for the recall. Dissolution testing measures how well a drug breaks down and releases its active ingredient when ingested. When a medication fails this test, it may not dissolve properly in the body, meaning patients could receive an inconsistent or insufficient dose.
The recall has been classified as Class II by the FDA, the middle tier of the agency's three-level system. A Class II recall indicates that the product "may cause temporary or medically reversible adverse health consequences," but that the probability of serious harm is remote.
No adverse reactions linked to this lot have been reported.
What Patients Should Know
Despite the recall, most Xanax users do not need to take any action. Viatris confirmed that the recall is being handled at the retailer level, meaning pharmacies and wholesalers are responsible for returning the affected product. Patients who want to verify their bottle can check for Lot #8177156 and contact their pharmacy with any questions.
A Viatris spokesperson confirmed that the vast majority of U.S. patients are already dispensed generic alprazolam, not the brand-name Xanax XR. Generics are not affected by this recall. Concerns about prescription drug pricing and access have put increased scrutiny on brand-name medications in recent months.
About Xanax and Alprazolam
Xanax is the brand name for alprazolam, a benzodiazepine prescribed to treat anxiety and panic disorders. It works by enhancing the effects of gamma-aminobutyric acid (GABA), a neurotransmitter that calms activity in the brain and central nervous system.
Approximately 3.6 million people in the United States receive prescriptions for Xanax each year, making it one of the most widely dispensed psychiatric medications in the country. While alprazolam is considered effective when used as prescribed, it carries a risk of dependence and is classified as a controlled substance.
What the FDA Recall Classification Means
The FDA uses a three-class system to categorize recalls by severity. A Class I recall is the most serious and applies when a product is reasonably likely to cause serious harm or death. Class III, the least urgent, is issued when adverse health consequences are unlikely.
This recall's Class II designation places it in the middle: the risk is real but considered limited and reversible. Checking lot numbers has become an important habit for consumers, as recalls like this egg recall have demonstrated in other product categories.
The California State Board of Pharmacy has urged pharmacies to review their quality assurance and recall procedures to determine whether any corrective action is required. Patients with questions about their prescriptions are advised to speak with their pharmacist or prescribing physician.
Curious for more stories that keep you informed and entertained? From the latest headlines to everyday insights, YourLifeBuzz has more to explore. Dive into what's next.